World Equity Group, Inc. Novartis Ag Transaction History

World Equity Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$92.57 - $107.37 $740 - $858	8 Added 0.05%	14,982 $1.6 Billion
Q1 2024 Jul 18, 2024	BUY	$95.27 - $108.47 $1.43 Million - $1.62 Million	14,974 New	14,974 $1.45 Billion
Q3 2023 Jul 22, 2024	SELL	$94.73 - $105.13 $134,895 - $149,705	-1,424 Reduced 9.5%	13,558 $1.38 Billion
Q2 2023 Aug 26, 2024	SELL	$92.52 - $104.91 $13.2 Million - $15 Million	-142,712 Reduced 91.31%	13,578 $1.37 Billion
Q1 2023 Aug 26, 2024	BUY	$80.03 - $92.81 $11.3 Million - $13.1 Million	141,308 Added 943.19%	156,290 $2.03 Billion
Q4 2022 Sep 06, 2024	BUY	$75.55 - $92.52 $27,349 - $33,492	362 Added 2.65%	14,027 $1.27 Billion
Q3 2022 Sep 06, 2024	SELL	$74.61 - $87.26 $98,261 - $114,921	-1,317 Reduced 8.79%	13,665 $1.04 Billion
Q2 2022 Sep 06, 2024	BUY	$80.52 - $93.75 $89,860 - $104,625	1,116 Added 9.28%	13,136 $1.11 Billion
Q1 2022 Sep 06, 2024	SELL	$80.11 - $90.62 $237,285 - $268,416	-2,962 Reduced 19.77%	12,020 $1.05 Billion

1,435

138M

1.48M

1.55M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of World Equity Group, Inc., based on Form 13F filings with the SEC.

Stay updated on World Equity Group, Inc. with notifications on news.